Comparing the clinical trial efficacy
versus
real-world effectiveness of treatments for multiple myeloma: a population-based study
Haematologica
.
2025 Jan 1;110(1):228-233.
doi: 10.3324/haematol.2024.285768.
Authors
Alissa Visram
1
,
Kelvin Kar-Wing Chan
2
,
Hsien Seow
3
,
Gregory Pond
3
,
Anastasia Gayowsky
4
,
Ghulam Rehman Mohyuddin
5
,
Arleigh McCurdy
6
,
Irwindeep Sandhu
7
,
Christopher Venner
8
,
Guido Lancman
9
,
Amaris Balitsky
3
,
Tom Kouroukis
3
,
Robert Bruins
10
,
Shaji Kumar
11
,
Rafael Fonseca
12
,
Hira Mian
3
Affiliations
1
The Ottawa Hospital Research Institute, Ottawa, Ontario. alisvisram@toh.ca.
2
Department of Medicine, Sunnybrook Health Sciences Center, University of Toronto.
3
Department of Oncology, McMaster University, Hamilton.
4
ICES McMaster, McMaster University, Hamilton, Ontario.
5
Department of Hematology, Huntsman Cancer Institute, Salt Lake City, Utah.
6
The Ottawa Hospital Research Institute, Ottawa, Ontario.
7
Department of Oncology, University of Edmonton, Edmonton.
8
Department of Medical Oncology, BC Cancer - Vancouver Centre, University of British Columbia, Vancouver.
9
Department of Medicine, University of Toronto, Toronto.
10
Eli Lilly Canada Inc., Toronto, ON.
11
Division of Hematology, Mayo Clinic, Rochester, Minnesota.
12
Division of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona.
PMID:
39219457
PMCID:
PMC11694101
DOI:
10.3324/haematol.2024.285768
No abstract available
Grants and funding
P50 CA186781/CA/NCI NIH HHS/United States